Current position:Home >Product >
trans-4-(4-indazol-1-ylpyrimidin-2-ylamino)-cyclohexanecarboxylic acid [3-hydroxy-1-(2-hydroxyethyl)propyl]-amide
trans-4-(4-indazol-1-ylpyrimidin-2-ylamino)-cyclohexanecarboxylic acid [3-hydroxy-1-(2-hydroxyethyl)propyl]-amide(1032452-15-5)
- Name: trans-4-(4-indazol-1-ylpyrimidin-2-ylamino)-cyclohexanecarboxylic acid [3-hydroxy-1-(2-hydroxyethyl)propyl]-amide
- Synonyms:
- Molecular Formula:
- Molecular Weight:438.53
- CAS Registry Number:1032452-15-5
- EINECS:
- Melting Point:
- Water Solubility:
Other Product
- 936751-33-6/C23H25Cl3O4
- 1175087-10-1/C64H88N10O6
- 1162260-44-7/4-[3-{6-[3-benzo[1,3]dioxol-5-yl-5-(3,3-dimethyl-piperidine-1-carbonyl)-phenoxy]-hexyl}-2-(2-carboxy-ethyl)-phenoxy]-butyric acid
- 1108711-09-6/3,5-dimethyl-pyridazine-4-carboxylic acid {5-[3-(3-fluoro-benzyl)-ureido]-[1,2,4]thiadiazol-3-ylmethyl}-methyl-amide
- 1034495-46-9/N-(2-t-butoxycarbonylaminophenyl)-4-[1-(2-dimethylaminoethyl)-3-(3-ethoxyphenyl)ureidomethyl]benzamide
- 916198-65-7/2-[[[[(2S)-2,3-dihydro-1-[[3'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]sulfonyl]-1H-indol-2-yl]carbonyl]amino]methyl]benzoic acid
- 1027328-56-8/6-chloro-quinoline-8-carboxylic acid (4-tert-butyl-benzyl)-[2-(4-fluoro-phenyl)-ethyl]-amide
- 1028685-94-0/[{3,5-dichloro-4-[4-hydroxy-3-(piperidine-1-sulfonyl)-phenoxy]-phenyl}-(4-hydroxy-phenoxycarbonyl)-amino]-acetic acid
- 1030379-78-2/1-[(4S)-4-cyclopropyl-2,5-dioxoimidazolidin-4-yl]-N-({4-[(2-ethylpyrimidin-5-yl)oxy]phenyl}methyl)-N-methylmethanesulfonamide
- 1030370-26-3/C33H31F3O3Se
- 1032452-15-5/trans-4-(4-indazol-1-ylpyrimidin-2-ylamino)-cyclohexanecarboxylic acid [3-hydroxy-1-(2-hydroxyethyl)propyl]-amide
- 928784-74-1/C22H16Cl2F3N3O4
- 1032525-81-7/(3S)-1-({8-[4-(1-aminocyclobutyl)phenyl]-9-phenyl[1,2,4]triazolo[3,4-f]-1,6-naphthyridin-3-yl}methyl)pyrrolidin-3-ol
- 1034265-16-1/1-(2-chloro-phenyl)-5-(4-chloro-phenyl)-4-(1H-tetrazol-5-ylmethyl)-1H-pyrazole-3-carboxylic acid [1-(3,4-difluoro-phenyl)-ethyl]-amide
- 1034265-23-0/1-(2-chloro-phenyl)-5-(4-chloro-phenyl)-4-(1H-tetrazol-5-ylmethyl)-1H-pyrazole-3-carboxylic acid [1-(3,5-difluoro-phenyl)-ethyl]-amide
- 1035488-37-9/(S)-2-(4-chlorophenyl)-1,1-dioxo-3-(3-(pyrazin-2-yloxy)phenyl)-1,2,5-thiadiazolidine
- 18605-76-0/N-Methyl-1-<2,6-dimethoxy-benzyl>-buten-(3)-ylamin-hydrochlorid
- 6062-08-4/(4-Benzhydryloxy-but-2-ynyl)-dimethyl-amine; hydrochloride
- 51407-55-7/(E)-4-(3-Bromo-4-isopropyl-phenyl)-but-3-enoic acid; compound with cyclohexylamine
- 13430-89-2/N-[3-(2,4-Dichloro-phenoxy)-propyl]-guanidine; compound with nitric acid
- 1031309-35-9/1-methyl-1H-imidazole-4-carboxylic acid (4-fluoro-3-trifluoromethyl-benzyl)-[4-(3-phenoxy-azetidin-1-yl)-cyclohexyl]-amide
- 1028759-39-8/C17H16N4O2S
- 1024607-47-3/3-hydroxy-1-(3-imidazol-1-yl-propyl)-4-phenyl-5-trifluoromethyl-1,5-dihydro-pyrrol-2-one
- 1023887-64-0/4-chloro-6-((2-(4-(((3-pyridin-2-ylpropyl)amino)methyl)phenyl)pyrrolidin-1-yl)carbonyl)benzene-1,3-diol
- 1109284-19-6/N-(2-methoxy-1-methylethyl)-3-[6-(1-methyl-1H-pyrazol-4-yl)pyrazolo[1,5-a]pyrimidin-3-yl]benzamide
- 1162259-78-0/4-(2-(2-carboxy-ethyl)-3-{6-[3-(2,3-dihydro-benzo[1,4]dioxin-6-yl)-5-(4-methyl-piperazine-1-carbonyl)-phenoxy]-hexyl}-phenoxy)-butyric acid
- 1013332-88-1/C2HF3O2*C17H16N6O6
- 1186105-25-8/C11H17NO
- 27688-68-2/(2-Methylaminomethyl-phenyl)-p-tolyl-methanol; hydrochloride
- 1035488-20-0/(R)-5-(3-((1-methyl-1H-tetrazol-5-yl)methoxy)phenyl)-1-(4-(4-chlorophenoxy)phenyl)pyrrolidin-2-one